EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, iRhythm Technologies's Enterprise Value is $5,092.8 Mil.
iRhythm Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.1 Mil. Therefore, iRhythm Technologies's EV-to-FCF for today is -4,818.14.
The historical rank and industry rank for iRhythm Technologies's EV-to-FCF or its related term are showing as below:
IRTC'
s EV-to-FCF Range Over the Past 10 Years
Min: -4778.27 Med: -56.49 Max: -21.02
Current: -4778.27
During the past 11 years, the highest EV-to-FCF of iRhythm Technologies was -21.02. The lowest was -4778.27. And the median was -56.49.
IRTC's EV-to-FCF is ranked worse than 100% of 391
companies
in the Medical Devices & Instruments industry
Industry Median: 25.34
vs IRTC: -4778.27
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for iRhythm Technologies's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's EV-to-FCF
For the Medical Devices subindustry, iRhythm Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's EV-to-FCF falls into.
iRhythm Technologies's current Enterprise Value is $5,092.8 Mil.
iRhythm Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
iRhythm Technologies's PE Ratio (TTM) for today is calculated as:
iRhythm Technologies's share price for today is $153.84.
iRhythm Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
iRhythm Technologies EV-to-FCF Related Terms
Thank you for viewing the detailed overview of iRhythm Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 